
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Urologic Oncology Branch [D. K. O., W. M. L.], Pathogenetics Unit, Laboratory of Pathology [D. K. O., C. E.], and Cancer Genome Anatomy Project, Office of the Director [J. W. G., M. R. E-B.], National Cancer Institute, NIH, Bethesda, Maryland 20892; Division of Cytokine Biology, Center for Biologics Evaluation Research, Food and Drug Administration, Bethesda, Maryland 20892 [C. P. P., E. F. P.]; and Department of Chemistry, Georgetown University, Washington, D.C. 20057 [C. P. P.]
The proportion of
unbound serum prostate-specific antigen (PSA; percent-free PSA) is
reported to be lower in men with prostate cancer compared to men with
benign prostates (U. H. Stenman et al., Cancer Res.,
51: 222226, 1991; H. Lilja et
al., Clin. Chem., 37: 16181625, 1991; D. L.
Woodrum et al., J. Urol., 159: 512,
1998; W. J. Catalona et al., J. Am. Med. Assoc.,
279: 15421547, 1998). The majority of
immunoreactive PSA in serum is complexed to
-1-antichymotrypsin
(ACT). Two major mechanistic questions have previously been unknown:
(a) Does PSA in human prostate cancer cells in tissue
exist in a free or bound form? and (b) Is PSA produced
by malignant cells in the free form because it has lost the ability to
form a complex with ACT? Laser capture microdissection (LCM) enables
the acquisition of pure populations of defined cell types from tissue
(M. R. Emmert-Buck et al., Science,
274: 998-1001, 1996; R. F. Bonner et
al., Science, 278: 14811483, 1997). This
technology provides a unique opportunity to study intracellular protein
composition and structure from human cells. In this study, we used LCM
to assess the bound versus free form of intracellular
PSA in both benign and malignant epithelium procured from prostate
tissue.
One-dimensional and two-dimensional PAGE were performed on cellular lysates from LCM-procured benign and malignant prostate epithelium from frozen tissue specimens. Western blotting analysis of one-dimensional PAGE gels revealed a strong band at Mr 30,000 (expected molecular weight of unbound PSA) in all cases demonstrating that the vast majority of intracellular tumor and normal PSA exists within cells in the "free" form. Binding studies showed that PSA recovered from LCM-procured cells retained the full ability to bind ACT, and two-dimensional PAGE Western analysis demonstrated that the PSA/ACT complex was stable under strong reducing conditions. We conclude that intracellular PSA exists in the "free" form and that binding to ACT occurs exclusively outside of the cell.
This article has been cited by other articles:
![]() |
E. M. Posadas, F. Simpkins, L. A. Liotta, C. MacDonald, and E. C. Kohn Proteomic analysis for the early detection and rational treatment of cancer--realistic hope? Ann. Onc., January 1, 2005; 16(1): 16 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, Y. Hong, Y.-X. Tan, H. Zhou, J.-H. Ai, S.-J. Li, L. Zhang, Q.-C. Xia, J.-R. Wu, H.-Y. Wang, et al. Accurate Qualitative and Quantitative Proteomic Analysis of Clinical Hepatocellular Carcinoma Using Laser Capture Microdissection Coupled with Isotope-coded Affinity Tag and Two-dimensional Liquid Chromatography Mass Spectrometry Mol. Cell. Proteomics, April 1, 2004; 3(4): 399 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Lapham, T. Romantseva, E. Petricoin, L. R. King, J. Manischewitz, M. B. Zaitseva, and H. Golding CXCR4 heterogeneity in primary cells: possible role of ubiquitination J. Leukoc. Biol., December 1, 2002; 72(6): 1206 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Craven, N. Totty, P. Harnden, P. J. Selby, and R. E. Banks Laser Capture Microdissection and Two-Dimensional Polyacrylamide Gel Electrophoresis : Evaluation of Tissue Preparation and Sample Limitations Am. J. Pathol., March 1, 2002; 160(3): 815 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Srinivas, S. Srivastava, S. Hanash, and G. L. Wright Jr Proteomics in Early Detection of Cancer Clin. Chem., October 1, 2001; 47(10): 1901 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stephan, K. Jung, M. Lein, P. Sinha, D. Schnorr, and S. A. Loening Molecular Forms of Prostate-specific Antigen and Human Kallikrein 2 as Promising Tools for Early Diagnosis of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1133 - 1147. [Abstract] [Full Text] |
||||
![]() |
F. Fend and M. Raffeld Laser capture microdissection in pathology J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |